 Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis
Kirsten de Groot, MD; Lorraine Harper, MD, PhD; David R.W. Jayne, MD, PhD; Luis Felipe Flores Suarez, MD, PhD; Gina Gregorini,
MD; Wolfgang L. Gross, MD; Rashid Luqmani, MD; Charles D. Pusey, MD, PhD; Niels Rasmussen, MD; Renato A. Sinico, MD; Vladimir
Tesar, MD, PhD; Philippe Vanhille, MD; Kerstin Westman, MD, PhD; and Caroline O.S. Savage, MD, PhD, for the EUVAS (European
Vasculitis Study Group)
19 May 2009 | Volume 150 Issue 10 | Pages 670-680 | Return to Article
Click for clinical information from PIER about:
What is PIER?
PIER (Physicians' Information and Education Resource) is an electronic resource from the American College of Physicians that provides
evidence-based clinical guidance in a format designed for rapid access at the point of care.
More information...
Experts in evidence-based medicine develop PIER content. All clinical recommendations in PIER include strength-of-recommendation
ratings based on the quality of underlying evidence. PIER content is continually updated.
PIER's module design allows users to drill down from more general to specific information, with immediate access to underlying
supporting evidence. PIER modules address prevention, screening, diagnosis, drug and non-drug therapy, and follow-up. They
also link to:
- A comprehensive drug resource
- PubMed abstracts and the full text of selected references
- Other ACP and non-ACP knowledge resources
- Tables, figures, algorithms, and video and audio clips.
|
